novo nordisk hims hers - Search News

News

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers

CBS News on MSN · 4d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

The Motley Fool on MSN · 3d

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

Insider on MSN · 3d

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

1h

Without GLP-1 Hims & Hers Is A $20s Per Share Stock -- Sell Call

Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...

3d

Novo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds

Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...

3d

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results